Evidence map›Paper›PMID 28676915›Full record

ArticleCytotechnology2017

Characterization of the new human pleomorphic undifferentiated sarcoma TP53-null cell line mfh-val2.

Rosario Gil-Benso, Javier Megías, Teresa San-Miguel, Sandra Pinto, Robert C Callaghan, Concha López-Ginés, Miguel Cerdá-Nicolás

Open access · greenAbstract read
In one paragraph

Article in Cytotechnology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Rosario Gil-BensoDepartment of Pathology, Faculty of Medicine and Odontology, Universitat de València, Avenida de Blasco Ibáñez 15, 46010, Valencia, Spain. rosario.gil-benso@uv.es.
Javier MegíasDepartment of Pathology, Faculty of Medicine and Odontology, Universitat de València, Avenida de Blasco Ibáñez 15, 46010, Valencia, Spain.
Teresa San-MiguelDepartment of Pathology, Faculty of Medicine and Odontology, Universitat de València, Avenida de Blasco Ibáñez 15, 46010, Valencia, Spain.
Sandra PintoLaboratory of Cytomics, Unidad Mixta CIPF-UVEG, Prince Felipe Research Centre, Valencia, Spain.
Robert C CallaghanDepartment of Pathology, Faculty of Medicine and Odontology, Universitat de València, Avenida de Blasco Ibáñez 15, 46010, Valencia, Spain.
Concha López-GinésDepartment of Pathology, Faculty of Medicine and Odontology, Universitat de València, Avenida de Blasco Ibáñez 15, 46010, Valencia, Spain.
Miguel Cerdá-NicolásDepartment of Pathology, Faculty of Medicine and Odontology, Universitat de València, Avenida de Blasco Ibáñez 15, 46010, Valencia, Spain.
Universitat de València · ESCentro de Investigacion Principe Felipe · ESHospital Universitari de Vic · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pleomorphic undifferentiated sarcoma (PUS), also called malignant fibrous histiocytoma, is a soft tissue sarcoma which occurs predominantly in the extremities. Its origin is a poorly defined mesenchymal cell, which derives to histiocytic and fibroblastic cells. The patient, a 58 year-old man, presented a lesion located in the forearm composed by spindle cells and multinucleated giant cells, which expressed vimentin and adopted a histological pattern formed by irregular-swirling fascicles. Cells were cultured in vitro and a new cell line was established. We characterized this new cell line by histological analyses, cytogenetics (using G-bands and spectral karyotype technique) and cytometric analyses. Cells were grown in culture for more than 100 passages. They had elongated or polygonal morphology. The cells presented a saturation rate of 70,980 cells/cm

Indexed as

Cell lineMalignant fibrous histiocytomaPleomorphic undifferentiated sarcomaTP53-null

Identifiers

PMID28676915
PMCPMC5507838
OpenAlexW2731113109

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.